Literature references on mucosal drug delivery systems : II

De Campos A.M.;Diebold Y.;Carvalho E.L.S.;Sánchez A.,José Alonso M. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharmaceutical Research, Springer. 2004; 21(5): 803-810(8).

Alvarez-Lorenzo, C., Hiratani, H., & Concheiro, A. (2006). Contact lenses for drug delivery: Achieving sustained release with novel systems. American Journal of Drug Delivery, 4, 131-151.

American Heart Association. (2005). Management of cardiac arrest recommended by the American Heart Association. Retrieved June 23, 2008, from http://circ.ahajournals.org/cgi/ content/full/112/24_suppl/IV-58

Bajwa, Z., & Warfield, C. (2008). Interventional approaches to the management of cancer pain. Retrieved on May 13, 2008, from http://www.uptodate.com/

Bielinska, A., Janxzak, K., & Landers, J. (2008). Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Thl polarized responses and neutralizing antibodies to primary HIV type isolates. AIDS Research and Human Retroviruses, 24, 271-281.

Bulletin Board. (2008). Nanomedicine, 3, 145-147.

Canadian Press. (2008). Canadian researchers develop automated anesthesia system dubbed McSleepy. Retrieved May 6, 2008, from http://www.googlenews.com/

Chandhari, M., & Mackenzie, P. (2007). Implantable technology for pain management. Anaesthesia & Intensive Care Medicine, 9, 69-74.

Clinical Trials. (2008, February). BioDelivery sciences to present BEMA fentanyl data at the 24th Annual Meeting of the American Academy of Pain Medicine. Retrieved on May 15, 2008, from http://www.drugs.corn/clinical_trials/biodeliverysciences-present- bema-fentanyl-data-24t

Cox, C. (n.d.). Treatment options gel with innovative drug delivery systems. Drug Delivery Technology Retrieved on May 16, 2008, from http://www.drugdeliverytech.com/cgi-bin/articles. cgi?idArticle=55

Gotfried, M. H., Shaw, J. P., Benton, B. M., Krause, K. M., Goldberg, M. R., Kitt, M. M., et al. (2008). Intrapulmonary distribution of intravenous televancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of televancin and other antibiotics. Antimicrobial Agents and Chemotherapy, 52, 92-97.

Hafeli, U. (2004). Magnetically modulated therapeutic systems. International Journal of Pharmaceutics, 277, 19-24.

Hirlekar, R., Patel, P, & Dand, N. (2008). Drug loaded erythrocytes: As novel drug delivery system. Current Pharmaceutical Design, 14, 63 70.

In-Pharma Technologist.com. (January 10, 2005). Contact lenses deliver drugs to eye. Retrieved on May 30, 2008, from http:// www.in-pharmatechnologist.com/news/ng.asp?id=57187-contact-lenses-deliver

Irani, F., Dankert, M., Brensinger, C., Bilker, W., Nair, S., Kohler, C., et al. (2004). Patient attitudes towards surgically implantable, long-term delivery of psychiatric medicine. Neuropsychopharmacology, 29, 960-968.

Jeng, M. J., Lee, Y. S., & Soong, W. J. (2007). Effects of perfluorochemicals for intrapulmonary vancomycin administration and partial liquid ventilation in an animal model of meconium-injured lungs. Acta Paediatrica Taiwanica, 48, 309-316.

Leary, S., Liu, C., & Apuzzo, M. (2006). Toward the emergence of nanoneurosurgery: Part II--Nanomedicine: Diagnostics and imaging at the nanoscale level. Neurosurgery, 58, 805-823.

Maloney, J., Uhland, S., & Polito, B. (2005). Electrothermally activated microchips for implantable drug delivery and biosensing. Journal of Controlled Release, 109, 244 255.

Medscape Medical News. (2002). 'Pain relief ball' cuts opioid use after gynecologic surgery. Retrieved on March 16, 2008, from http://wwwmedscape.com/viewarticle/433317
Morrow, J., Bawa, R., & Wei, C. (2007). Recent advances in basic and clinical nanomedicine. Medical Clinics of North America, 91,805 843.

Nova Science Now. (n.d.). Cancer nanotech. Retrieved May 10, 2008, from http://www.pbs.org/wgbh/nova/sciencenow/3209/ 03-canc-nf.html
Skryabina, E., & Dunn, T. (2006). Disposable infusion pumps. American Journal of Health System Pharmacists, 63, 1260 1268.

Tasciotti, E., Liu, X., & Bhavane, R. (2008). Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nature Nanotechnology, 3, 151 157.

Triangle Business Journal. (2008, May). BDSI's pain patch does well in human trial. Retrieved May 30, 2008 from http:// triangle.bizjournals.com/triangle/stories/2008/05/05/daily28. html.

Wermeling, D. P, Miller, J. L., & Rudy, A. C. (n.d.). Systemic" Intranasal drug delivery: concepts and applications. Drug Delivery Technology. Retrieved March 16, 2008, from http://www. drugdeliverytech.com/cgi-bin/articles.cgi?idArticle=22

Wynne, A. L., Woo, T. M., & Olyaei, A. J. (2007). Pharmacotherapeutics for nurse practitioner prescribers (2nd ed.). Philadelphia: EA. Davis.

Yih, T., & Al-Fandi, M. (2006). Engineered nano particles as precise drug delivery systems. Journal of Cellular Biochemistry, 97, 1184-1190.

Young, E. (2004). Drug-delivering contact lenses revealed. NewScientist.com news service. Retrieved June 1,2008, from http://newsscientist.com/article.ns?id=dn6597

Angelia Colwell Berkowitz, BSN RN CRNI, is a graduate student at The University of Texas Health Science Center at San Antonio, San Antonio, TX.

The next series shall comprise of the formulation challenges as well as quality considerations and regulatory challenges faced during the development of mucosal DDS.

For an expert opinion on formulation development of peptide/ protein molecules http://www.drshrutibhat.com

My other blog that might be of interest- http://www.qa-expert.com/